E-TENDER ENQUIRY FORM FOR RATE CONTRACT No. 154 FOR SUPPLY OF DRUGS AND DRESSINGS

Promethazine Syp- Each 5 ml to contain: Promethazine 5mg

Promethazine Inj- Each ml to contain: Promethazine 25mg

Artificial Tears Drop- Each Vial to contain: Polyvinyl Alcohol 1.4%, Povidone 0.6%, Benzalkonium Chloride 0.01%

Sodium Hyaluronate Inj (Intra Articular)- Each PFS to contain: Sodium Hyaluronate 25mg, Sodium Chloride, Sodium Phosphate Dibasic And Monobasic Qs

Tropicamide Eye Drop- Each Vial to contain: Tropicamide 0.8%, Phenyl Ephrine Hcl 5%

Indomethacin Tab/Cap- Each Tab/Cap to contain: Indomethacin 25 mg

Indomethacin SR Tab/Cap- Each SR Tab/Cap to contain: Indomethacin 75 mg

Acyclovir Eye Oint- Each Tube to contain: Acyclovir I.P.3%

Polymixin, Neomycin Eye Oint- Each gm to contain: Polymixin B Sulphate 5000 IU, Neomycin Sulphate 3400 IU, Zinc Bacitracin 400 IU 5gm to 10gm Tube

Antacid Gel- Each 5ml to contain: Aluminium Hydroxide 6g, Mag. Hydroxide 80mg., Activated Dimethicone 100mg, Deglycycrrhizinated Liquorice Eqv. to Liquorice 400mg.

Otilonium Bromide Tab/Cap- Each Tab/Cap to contain: Otilonium Bromide 40 mg

Bacillus Clausii Spores Susp - Each 5ml to contain: Bacillus clausii spores 2 Billion spores, susp.in 5ml distilled water

Euphorbia Prostata Tab/Cap - Each Tab/Cap to contain: Euphorbia Prostata dry extract ethanolic 80% (v/v) 100mg

Moxifloxacin Eye Oint- Each Tube to contain: Moxifloxacin 0.5%

Dorzolamide+Timolol Eye Drop- Each Vial to contain: Dorzolamide 2% ,Timolol I.P. 0.5%

Hylan G-F20 Injection - Each contain: Hylan G-F20

Tocilizumab Inj 80mg - Each Vial to contain: Tocilizumab 80 mg

Tocilizumab Inj 200mg - Each Vial to contain: Tocilizumab 200 mg

Tocilizumab Inj 400mg - Each Vial to contain: Tocilizumab 400 mg

Racecadotril Dispersible Tab/Cap- Each Disp Tab/Cap to contain: Racecadotril 10mg

Racecadotril Dispersible Tab/Cap- Each Disp Tab/Cap to contain: Racecadotril 30mg

Buprenorphine Transdermal Patch - Each Transdermal patch to contain : Buprenorphine 5 mcg/hr. Area containing active substance 6.25sqcm

Buprenorphine Transdermal Patch - Each Transdermal patch to contain : Buprenorphine 10 mcg/hr. Area containing active substance 12.5sqcm

Buprenorphine Transdermal Patch - Each Transdermal patch to contain : Buprenorphine 20 mcg/hr. Area containing active substance 25sqcm

Dorzolamide Eye Drop- Each Vial to contain: Dorzolamide 2%

Metronidazole Oral Gel- Each Tube to contain: Metronidazole 1%, Chlorhexidine 0.25%

Prucalopride Tab/Cap- Each Tab/Cap to contain: Prucalopride 1mg

Aflibercept Injection 40 Mg / Mlaflibercept (R-DNA Origin) Solution For Intravitreal Injection in Vial Each Pack to contain: 1 Vial and a 18 G Sterile Filter Needle 278 Microliters/Vial Each Single Dose Vial Provides A Usable Amount To Deliver A Single Dose Of 50 Microliters Containing 2mg Aflibercept

Lubricating Eye Drop- Each Vial to contain: Povidone 20mg/ml, Preservative Free, Phosphate Free

Resistant Bacillus Clausii Tab/Cap: Each Tab/Cap Contains:2 billion spores of polyantibiotic-Resistant Bacillus Clausii

Paracetamol Suppository- Each Suppository to contain: Paracetamol 250 mg

Paracetamol Suppository- Each Suppository to contain: Paracetamol 80 mg

Each PFS to contain: Sodium Hyaluronate BP 80mg to 90mg (Cross Linked) Phosphate Buffer Saline Q.S., 1 PFS

Xylometazoline Nasal Spray- Each Nasal Spray of 0.14 ml to contain: Xylometazoline Hydrochloride 0.14 mg. Preservative Free In 3K System.

Balanced Diet Soln- Each 1 ml to contain : Sodium Chloride (NaCl) 6.4 mg, Potassium Chloride (KCl) 0.75 mg, Calcium Chloride Dihydrate (CaCl2•2H2O) 0.48 mg, Magnesium Chloride Hexahydrate (MgCl2•6H2O) 0.3 mg, Sodium Acetate Trihydrate (C2H3NaO2•3H2O) 3.9 mg, Sodium Citrate Dihydrate (C6H5Na3O7•2H2O) 1.7 mg, Sodium Hydroxide and/or hydrochloric acid (to adjust pH), and water for injection. The pH is approximately 7.5. The osmolality is approximately 300 mOsm/Kg.

Intravitreal Dexamethasone Implant- Each inj to contain: Intravitreal Dexamethasone 0.7mg

Prochlorperazine Mesylate Inj- Each ml to contain: Prochlorperazine Mesylate 12.5mg

Sodium Picosulphate Tab/Cap- Each Tab/Cap to contain: Sodium Picosulphate 10 mg Tablet

Silymarin Tab/Cap- Each Tab/Cap to contain: Silymarin 70mg

Bisacodyl Suppository- Each Suppository to contain: Bisacodyl 10mg

Mefanamic Acid Syp- Each 5ml to contain: Mefanamic Acid 100mg

Paracetamol, Lignocaine Inj- Each ml to contain: Paracetamol IP 150mg, Lignocaine Hydrochloride IP 1% w/v, Benzyl Alcohol (As Preservative) IP 1% v/v, Water For Injection IP Q.S.

Ranibizumab Inj- Each Pre-Filled Syringe to contain: 1.65mg of Ranibizumab in 0.165 ml Solution

Intracameral Lignocaine Inj- Each ml to contain: Intracameral Lignocaine 1% Injection

Proparacaine Eye Drop- Each ml to contain: Proparacaine 0.5%

Pilocarpine Inj: Each ml to contain: Pilocarpine 0.5 %

Sodium Hyaluronate Inj- Each ml to contain : Sodium Hyaluronate 10mg, Dibasic Sodium Phosphate 0.56 mg, Monobasic Sodium Phosphate 0.04mg, Sodium Chloride-8.4mg

Hydroxypropyl Methylcellulose Ophthalmic Solution For Surgical Use: Each PFS to contain: Hydroxypropyl Methylcellulose 2%, Preservative Free

Fluorometholone + Tobramycin Eye Drop- Each ml to contain: Fluorometholone 0.1% w/v, Tobramycin 0.3% w/v

Fluorometholone Eye Drop- Each ml to contain: Fluorometholone 0.1% w/v

Hydroxypropyl Methylcellulose Eye Drop: Each ml to contain: Hydroxypropyl Methylcellulose 0.7% w/v, Borax 0.19% w/v, Boric Acid 0.19% w/v, Sodium Chloride 0.45% w/v, Potassium Chloride 0.37% w/v, Benzalkonium Chloride 0.01% w/v

Naphazoline, Chlorpheniramine Maleate, Methylcellulose Eye Drop- Each Vial to contain: Naphazoline 0.1% w/v, Chlorpheniramine Maleate 0.01% w/v, Methylcellulose 0.2% w/v

Natamycin Eye Drop- Each ml to contain: Natamycin 5% w/v

Pilocarpine Eye Drop- Each ml to contain : Pilocarpine Nitrate 2% w/v

Sodium Chloride Eye Drop- Each ml to contain: Sodium Chloride 5% w/v

Sodium Chloride Eye Oint/Cream: Each gm to contain: Sodium Chloride 6% w/v

Timolol +Brimonidine Eye Drop- Each Vial to contain: Timolol 5mg +Brimonidine 1.5mg

Atropine Eye Oint/Cream: Each gm to contain Atropine Sulfate 1%

Hypromellose Eye Gel: Each Tube to contain Hypromellose 2%

Ofloxacin Eye Oint/Cream- Each gm to contain: Ofloxacin 0.3 %

Prednisolone Eye Drop- Each ml to contain: Prednisolone Acetate 1%

Tropicamide Eye Drop- Each ml to contain: Tropicamide 1% w/v

Homatropine Eye Drop- Each ml to contain: Homatropine Hydrobromide IP 2% w/v , Benzalkonium Chloride 0.01% w/v (As Preservative)

Loperamide Tab/Cap- Each Tab/Cap contain: Loperamide 2mg

Glycerol Susp/Syp- Each Bottle to contain: Oral Glycerol 10%

Cyclopent Drop- Each Vial/Phial to contain: Cyclopent 1.0%

Ligonocaine Hydrochloride- Each Vial/Phial to contain: Ligonocaine Hydrochloride 4%

Prochlorperazine Tab/Cap- Each Tab/Cap to contain: Prochlorperazine Maleate 5 mg

Mascot Health Series Pvt. Ltd.

Martin & Brown Biosciences

TORRENT PHARMACEUTICALS LTD

UNICURE INDIA LIMITED

MICRO LABS LTD

VIVIMED LABS LTD

Allergan India Pvt ltd

Bidder Name

VIVIMED LABS LTD

MICRO LABS LTD

UNICURE INDIA LIMITED

Mascot Health Series Pvt. Ltd.

TORRENT PHARMACEUTICALS LTD

AEON FORMULATIONS PRIVATE LIMITED

Allergan India Pvt ltd

Martin & Brown Biosciences

TORRENT PHARMACEUTICALS LTD

Item No.: 2055

Item No.: 2421

Allergan India Pvt ltd

MICRO LABS LTD

Item No.: 1100

Item No.: 2257

AEON FORMULATIONS PRIVATE LIMITED

Martin & Brown Biosciences

Item No.: 14

VIVIMED LABS LTD

Item No.: 562

Item No.: 1601

Item No.: 1924

Item No.: 2287

Item No.: 2295